| Year |
Title |
Altmetric |
| 2022
|
Efficacy of hope: Analysis of organ quality and availability among deceased HIV-positive donors.
Transplant Infectious Disease.
24.
2022
|
|
| 2022
|
Associations between female birth sex and risk of chronic kidney disease development among people with HIV in the USA: A longitudinal, multicentre, cohort study.
EClinicalMedicine.
53.
2022
|
|
| 2022
|
Diabetes-free survival among living kidney donors and non-donors with obesity: A longitudinal cohort study.
PLoS One.
17.
2022
|
|
| 2022
|
Impact of refitted race-free eGFR formula on obesity pharmacotherapy options.
Obesity.
30:2204-2212.
2022
|
|
| 2022
|
A roadmap for human trials of xenotransplantation.
Journal of Clinical Investigation.
132.
2022
|
|
| 2022
|
Perpetuating Disparity: Failure of the Kidney Transplant System to Provide the Most Kidney Transplants to Communities With the Greatest Need.
Annals of Surgery.
276:597-604.
2022
|
|
| 2022
|
Reducing Racial Disparities in Access to Transplant in the United States One Step at a Time.
Clinical Journal of the American Society of Nephrology.
17:1439-1441.
2022
|
|
| 2022
|
County-level Differences in Liver-related Mortality, Waitlisting, and Liver Transplantation in the United States.
Transplantation.
106:1799-1806.
2022
|
|
| 2022
|
Greater community vulnerability is associated with poor living donor navigator program fidelity.
Surgery.
172:997-1004.
2022
|
|
| 2022
|
Lost potential and missed opportunities for DCD liver transplantation in the United States
2022
|
|
| 2022
|
COVID-19 and transplantation—Data censoring.
American Journal of Transplantation.
22:1958-1962.
2022
|
|
| 2022
|
COVID-19 Vaccination and Remdesivir are Associated With Protection From New or Increased Levels of Donor-Specific Antibodies Among Kidney Transplant Recipients Hospitalized With COVID-19.
Transplant International.
35.
2022
|
|
| 2022
|
A Sex-Adjusted Model for End-Stage Liver Disease Sodium Score for Equality in Liver Transplant.
JAMA Surgery.
157:627.
2022
|
|
| 2022
|
Abnormal time-zero histology is predictive of kidney transplant outcomes.
Clinical Transplantation.
36.
2022
|
|
| 2022
|
Dialysis Nonadherence and Kidney Transplant Outcomes: A Retrospective Cohort Study.
American Journal of Kidney Diseases.
80:46-54.
2022
|
|
| 2022
|
The science of xenotransplantation for nephrologists.
Current Opinion in Nephrology and Hypertension.
31:387-393.
2022
|
|
| 2022
|
The “Broken rung” in transplantation surgery
2022
|
|
| 2022
|
National Landscape of Human Immunodeficiency Virus-Positive Deceased Organ Donors in the United States.
Clinical Infectious Diseases.
74:2010-2019.
2022
|
|
| 2022
|
Patient survival following third time liver transplant in the United States in the MELD era
2022
|
|
| 2022
|
Donor-reported barriers to living kidney donor follow-up.
Clinical Transplantation.
36.
2022
|
|
| 2022
|
First clinical-grade porcine kidney xenotransplant using a human decedent model.
American Journal of Transplantation.
22:1037-1053.
2022
|
|
| 2022
|
Hepatic macrosteatosis in the US pediatric deceased liver donor population.
Pediatric Transplantation.
26.
2022
|
|
| 2022
|
Progress towards solving the donor organ shortage.
Nature Reviews Nephrology.
2022
|
|
| 2022
|
Reclassification of CKD in living kidney donors with the refitted race-free eGFR formula
2022
|
|
| 2021
|
Addressing ethical confusion in deceased donation and transplantation research: the need for dedicated guidance.
Transplant International.
34:2459-2468.
2021
|
|
| 2021
|
Evaluation of Community-Level Vulnerability and Racial Disparities in Living Donor Kidney Transplant.
JAMA Surgery.
156:1120-1129.
2021
|
|
| 2021
|
Impact of Social Vulnerability on Access to Educational Programming Designed to Enhance Living Donation
2021
|
|
| 2021
|
Editorial: Sensitization and Desensitization in Organ Transplantation.
Frontiers in Immunology.
12.
2021
|
|
| 2021
|
Gender disparities in transplantation.
Current Opinion in Organ Transplantation.
26:513-520.
2021
|
|
| 2021
|
Optimal Timing of Administration of Direct-acting Antivirals for Patients With Hepatitis C-associated Hepatocellular Carcinoma Undergoing Liver Transplantation.
Annals of Surgery.
274:613-620.
2021
|
|
| 2021
|
Significance and innovation: cornerstones of a successful grant application.
Surgery.
170:1080-1082.
2021
|
|
| 2021
|
Survival following simultaneous liver-lung versus liver alone transplantation: Results of the US national experience
2021
|
|
| 2021
|
New Perspectives on Desensitization in the Current Era - An Overview.
Frontiers in Immunology.
12.
2021
|
|
| 2021
|
APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (contra).
Kidney International.
100:30-32.
2021
|
|
| 2021
|
Obesity is a risk factor for progression to kidney transplant waitlisting after liver transplantation.
Clinical Transplantation.
35.
2021
|
|
| 2021
|
Self-advocacy is associated with lower likelihood of living donor kidney transplantation
2021
|
|
| 2021
|
Updated Pathway to Micro-elimination of Hepatitis C Virus in the Hemodialysis Population.
Kidney International Reports.
6:1788-1798.
2021
|
|
| 2021
|
Early Outcomes With the Liver-kidney Safety Net.
Transplantation.
105:1261-1272.
2021
|
|
| 2021
|
What Therapeutic Regimen Will Be Optimal for Initial Clinical Trials of Pig Organ Transplantation?.
Transplantation.
105:1143-1155.
2021
|
|
| 2021
|
Analysis of Linguistically and Culturally Tailored Initiatives in Websites of Kidney Transplant Programs in the United States Between 2013-2018
2021
|
|
| 2021
|
Effects of Geographic Redistribution Policy on Access to Organ Transplant-In Reply.
JAMA Surgery.
156:289-290.
2021
|
|
| 2021
|
Eplet mismatch scores and de novo donor-specific antibody development in simultaneous pancreas-kidney transplantation.
Human Immunology.
82:139-146.
2021
|
|
| 2021
|
Leveraging Frailty to Mitigate Sex-Based Disparities in Access to Liver Transplant: Justice in Allocation.
JAMA Surgery.
156:263.
2021
|
|
| 2021
|
The Living Donor Navigator Program Provides Support Tools for Caregivers
2021
|
|
| 2021
|
Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement.
American Journal of Transplantation.
21:475-483.
2021
|
|
| 2021
|
Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement.
American Journal of Transplantation.
21:460-474.
2021
|
|
| 2021
|
Cardiac Mortality following Kidney Transplantation: Progress Made but Still Room for Improvement.
Transplantation.
278-279.
2021
|
|
| 2021
|
Cognitive mapping as an approach to facilitate organ donation among African Americans
2021
|
|
| 2021
|
Incidence and Outcomes of COVID-19 in Kidney and Liver Transplant Recipients With HIV: Report From the National HOPE in Action Consortium.
Transplantation.
105:216-224.
2021
|
|
| 2021
|
Integrating APOL1 Kidney-risk Variant Testing in Live Kidney Donor Evaluation: An Expert Panel Opinion.
Transplantation.
2132-2134.
2021
|
|
| 2021
|
Pig kidney xenotransplantation: Progress toward clinical trials.
Clinical Transplantation.
35.
2021
|
|
| 2021
|
Suggested Patient Selection Criteria for Initial Clinical Trials of Pig Kidney Xenotransplantation in the United States.
Transplantation.
1904-1908.
2021
|
|
| 2020
|
Human immunodeficiency virus from life taking to life giving: expanding the donor pool by using HIV-positive donors.
Current Opinion in Organ Transplantation.
25:626-630.
2020
|
|
| 2020
|
The tetraspanin CD151 marks a unique population of activated human T cells.
Scientific Reports.
10.
2020
|
|
| 2020
|
Bariatric surgery to achieve transplant in end-stage organ disease patients: A systematic review and meta-analysis
2020
|
|
| 2020
|
Commentary on: "Outcomes in Kidney Transplantation Between Veterans Affairs and Civilian Hospitals: Considerations in the Context of the MISSION Act".
Annals of Surgery.
272:511.
2020
|
|
| 2020
|
Exacerbating Racial Disparities in Kidney Transplant: The Consequences of Geographic Redistribution.
JAMA Surgery.
155:679-681.
2020
|
|
| 2020
|
Quantifying Sex-Based Disparities in Liver Allocation.
JAMA Surgery.
155.
2020
|
|
| 2020
|
Use of Patient Navigators to Reduce Barriers in Living Donation and Living Donor Transplantation.
Current Transplantation Reports.
7:72-80.
2020
|
|
| 2020
|
Combined Thoracic-Kidney Transplantation Practices May Exacerbate Existing Geographic Disparities in Access to Deceased Donor Kidney Transplantation.
Journal of Heart and Lung Transplantation.
39:S366-S367.
2020
|
|
| 2020
|
Regional Variation in Appropriateness of Non-Hepatocellular Carcinoma Model for End-Stage Liver Disease Exception.
Journal of the American College of Surgeons.
230:503-512.e8.
2020
|
|
| 2020
|
A Qualitative Assessment of the Living Donor Navigator Program to Identify Core Competencies and Promising Practices for Implementation
2020
|
|
| 2020
|
Donor-Recipient Relationship and Risk of ESKD in Live Kidney Donors of Varied Racial Groups.
American Journal of Kidney Diseases.
75:333-341.
2020
|
|
| 2020
|
Tackling the weight list problem.
American Journal of Transplantation.
20:329-330.
2020
|
|
| 2020
|
Enhanced Advocacy and Health Systems Training through Patient Navigation Increases Access to Living-donor Kidney Transplantation.
Transplantation.
122-129.
2020
|
|
| 2020
|
Geographic differences in population health and expected organ supply in the Gulf Coast Region of the United States compared to non-Gulf States.
Transplantation.
421-427.
2020
|
|
| 2020
|
Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-positive Recipients in the Direct-acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?.
Transplantation.
1215-1228.
2020
|
|
| 2020
|
Positive crossmatch kidney transplantation: State of the art and future perspectives.
Current Pharmaceutical Design.
26:3460-3467.
2020
|
|
| 2020
|
Redefining the Influence of Ethnicity on Simultaneous Kidney and Pancreas Transplantation Outcomes: A 15-year Single-center Experience.
Annals of Surgery.
271:177-183.
2020
|
|
| 2020
|
Social determinants of health: Going beyond the basics to explore racial disparities in kidney transplantation.
Transplantation.
1324-1325.
2020
|
|
| 2019
|
Patient Perspectives on Weight Management for Living Kidney Donation.
Journal of Surgical Research.
244:50-56.
2019
|
|
| 2019
|
Donation approval among obese living kidney donor candidates: The impact of metabolic syndrome.
Surgery.
166:940-946.
2019
|
|
| 2019
|
Get on with it!—A novel allocation strategy to reduce kidney discards.
American Journal of Transplantation.
19:2971-2972.
2019
|
|
| 2019
|
Self-reported incident hypertension and long-term kidney function in living kidney donors compared with healthy nondonors.
Clinical Journal of the American Society of Nephrology.
14:1493-1499.
2019
|
|
| 2019
|
Mitigating Racial and Sex Disparities in Access to Living Donor Kidney Transplantation: Impact of the Nation's Longest Single-center Kidney Chain.
Annals of Surgery.
270:639-646.
2019
|
|
| 2019
|
Obesity and long-term mortality risk among living kidney donors.
Surgery.
166:205-208.
2019
|
|
| 2019
|
Patient-reported outcome measures for life participation in kidney transplantation: A systematic review.
American Journal of Transplantation.
19:2306-2317.
2019
|
|
| 2019
|
Center variation and risk factors for failure to complete 6 month postdonation follow-up among obese living kidney donors.
Transplantation.
103:1450-1456.
2019
|
|
| 2019
|
Ethnic and age disparities in outcomes among liver transplant waitlist candidates.
Transplantation.
103:1425-1432.
2019
|
|
| 2019
|
Time for reform in transplant program–specific reporting: AST/ASTS transplant metrics taskforce.
American Journal of Transplantation.
19:1888-1895.
2019
|
|
| 2019
|
Establishing a core outcome measure for life participation: A standardized outcomes in nephrology-kidney transplantation consensus workshop report.
Transplantation.
103:1199-1205.
2019
|
|
| 2019
|
Mortality and Kidney Transplantation Outcomes Among Hepatitis C Virus–Seropositive Maintenance Dialysis Patients: A Retrospective Cohort Study.
American Journal of Kidney Diseases.
73:815-826.
2019
|
|
| 2019
|
Optimal timing of hepatitis C treatment among HIV/HCV coinfected ESRD patients: Pre- vs posttransplant.
American Journal of Transplantation.
19:1806-1819.
2019
|
|
| 2019
|
Kidney transplantation in a HIV-positive recipient.
Clinical Journal of the American Society of Nephrology.
14:614-616.
2019
|
|
| 2019
|
Disparity in access to kidney allograft offers among transplant candidates with human immunodeficiency virus.
Clinical Transplantation.
33.
2019
|
|
| 2019
|
CYP3A5 genotype affects time to therapeutic tacrolimus level in pediatric kidney transplant recipients.
Pediatric Transplantation.
23.
2019
|
|
| 2018
|
Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop.
Kidney International.
94:1053-1068.
2018
|
|
| 2018
|
Population Health, Ethnicity, and Rate of Living Donor Kidney Transplantation.
Transplantation.
102:2080-2087.
2018
|
|
| 2018
|
Can you hear me now? Patient preferences for evaluating kidney transplant centers.
American Journal of Transplantation.
18:2624.
2018
|
|
| 2018
|
Population level outcomes and cost-effectiveness of hepatitis C treatment pre- vs postkidney transplantation.
American Journal of Transplantation.
18:2483-2495.
2018
|
|
| 2018
|
Response to “It is time to revise the kidney allocation system to restore the pediatric advantage”.
American Journal of Transplantation.
18:2367.
2018
|
|
| 2018
|
Expand the pool of living donors for kidney transplantation.
Clinical Journal of the American Society of Nephrology.
13:1142-1143.
2018
|
|
| 2018
|
Impact of the new kidney allocation system A2/A2B → B policy on access to transplantation among minority candidates.
American Journal of Transplantation.
18:1947-1953.
2018
|
|
| 2018
|
Decreasing deceased donor transplant rates among children (≤6 years) under the new kidney allocation system.
American Journal of Transplantation.
18:1690-1698.
2018
|
|
| 2018
|
In Reply to ‘Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline’.
American Journal of Kidney Diseases.
72:155.
2018
|
|
| 2018
|
Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors.
Annals of Surgery.
267:1161-1168.
2018
|
|
| 2018
|
Expanding clarity or confusion? Volatility of the 5-tier ratings assessing quality of transplant centers in the United States.
American Journal of Transplantation.
18:1494-1501.
2018
|
|
| 2018
|
Response to: Regarding “HIV protease inhibitors and mortality following kidney transplantation”.
American Journal of Transplantation.
18:1571.
2018
|
|
| 2018
|
Evaluation of Kidney Donors: Core Curriculum 2018.
American Journal of Kidney Diseases.
71:737-747.
2018
|
|
| 2018
|
Assessing emergency department utilization in the era of population health.
American Journal of Transplantation.
18:777-778.
2018
|
|
| 2018
|
Kidney transplantation and waitlist mortality rates among candidates registered as willing to accept a hepatitis C infected kidney.
Transplant Infectious Disease.
20.
2018
|
|
| 2018
|
Landscape of ABO-Incompatible Live Donor Kidney Transplantation in the US.
Journal of the American College of Surgeons.
226:615-621.
2018
|
|
| 2018
|
Long Cold Ischemia Times in Same Hospital Deceased Donor Transplants.
Transplantation.
102:471-477.
2018
|
|
| 2018
|
Race but not Hepatitis C co-infection affects survival of HIV+ individuals on dialysis in contemporary practice.
Kidney International.
93:706-715.
2018
|
|
| 2018
|
Patient and Kidney Allograft Survival in Recipients with End-Stage Renal Disease from Amyloidosis.
Transplantation.
102:300-309.
2018
|
|
| 2018
|
Living Kidney Donor Phenotype and Likelihood of Postdonation Follow-up.
Transplantation.
102:135-139.
2018
|
|
| 2018
|
Urologic malignancies in kidney transplantation.
American Journal of Transplantation.
18:13-22.
2018
|
|
| 2017
|
Impact of Protease Inhibitor–Based Anti-Retroviral Therapy on Outcomes for HIV+ Kidney Transplant Recipients.
American Journal of Transplantation.
17:3114-3122.
2017
|
|
| 2017
|
Apolipoprotein L1 Gene Effects on Kidney Transplantation.
Seminars in Nephrology.
37:530-537.
2017
|
|
| 2017
|
Expanding the use of hepatitis C–viremic kidney donors.
Kidney International.
92:1031-1033.
2017
|
|
| 2017
|
PROviding Better ACcess To ORgans: A comprehensive overview of organ-access initiatives from the ASTS PROACTOR Task Force.
American Journal of Transplantation.
17:2546-2558.
2017
|
|
| 2017
|
Quantifying postdonation risk of ESRD in living kidney donors.
Journal of the American Society of Nephrology.
28:2749-2755.
2017
|
|
| 2017
|
Effect of kidney donor hepatitis C virus serostatus on renal transplant recipient and allograft outcomes.
Clinical Kidney Journal.
10:564-572.
2017
|
|
| 2017
|
Patterns of primary care utilization before and after living kidney donation.
Clinical Transplantation.
31.
2017
|
|
| 2017
|
Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney Donors.
American Journal of Transplantation.
17:1823-1832.
2017
|
|
| 2017
|
The Authors Reply.
Kidney International.
91:1256.
2017
|
|
| 2017
|
Abdominal lean muscle is associated with lower mortality among kidney waitlist candidates.
Clinical Transplantation.
31.
2017
|
|
| 2017
|
Obesity increases the risk of end-stage renal disease among living kidney donors.
Kidney International.
91:699-703.
2017
|
|
| 2017
|
Survival benefit of kidney transplantation in HIV-infected patients.
Annals of Surgery.
265:604-608.
2017
|
|
| 2017
|
Lymphocyte-depleting induction therapy lowers the risk of acute rejection in African American pediatric kidney transplant recipients.
Pediatric Transplantation.
21.
2017
|
|
| 2017
|
Access to kidney transplantation among HIV-infected waitlist candidates.
Clinical Journal of the American Society of Nephrology.
12:467-475.
2017
|
|
| 2017
|
Increased Mortality and Graft Loss With Kidney Retransplantation Among Human Immunodeficiency Virus (HIV)–Infected Recipients.
American Journal of Transplantation.
17:173-179.
2017
|
|
| 2017
|
Kidney transplantation of highly sensitized recipients under the new kidney allocation system: A reflection from five different transplant centers across the United States.
Human Immunology.
78:30-36.
2017
|
|
| 2017
|
Survival benefit of transplantation with a deceased diabetic donor kidney compared with remaining on the waitlist.
Clinical Journal of the American Society of Nephrology.
12:974-982.
2017
|
|
| 2016
|
Overcoming immunologic barriers to kidney transplantation: Desensitization and paired donation.
Current Surgery Reports.
4.
2016
|
|
| 2016
|
Dosing Eculizumab for Antibody-Mediated Rejection in Kidney Transplantation: A Case Report.
Transplantation Proceedings.
48:3099-3105.
2016
|
|
| 2016
|
Insurance Type and Solid Organ Transplantation Outcomes: A Historical Perspective on How Medicaid Expansion Might Impact Transplantation Outcomes.
Journal of the American College of Surgeons.
223:611-620.e4.
2016
|
|
| 2016
|
Anti–Blood Group Antibodies in Intravenous Immunoglobulin May Complicate Interpretation of Antibody Titers in ABO-Incompatible Transplantation.
American Journal of Transplantation.
16:2483-2486.
2016
|
|
| 2016
|
Identification of Optimal Donor–Recipient Combinations Among Human Immunodeficiency Virus (HIV)–Positive Kidney Transplant Recipients.
American Journal of Transplantation.
16:2377-2383.
2016
|
|
| 2016
|
Induction Immunosuppression and Clinical Outcomes in Kidney Transplant Recipients Infected With Human Immunodeficiency Virus.
American Journal of Transplantation.
16:2368-2376.
2016
|
|
| 2016
|
Inpatient mortality among solid organ transplant recipients hospitalized for sepsis and severe sepsis.
Clinical Infectious Diseases.
63:186-194.
2016
|
|
| 2016
|
A systematic review of the use of expandable cages in the cervical spine.
Neurosurgical Review.
39:1-11.
2016
|
|
| 2016
|
Long-Term outcomes after liver transplantation among human immunodeficiency virus-infected recipients.
Transplantation.
100:141-146.
2016
|
|
| 2015
|
Hospital-onset Clostridium difficile infection among solid organ transplant recipients.
American Journal of Transplantation.
15:2970-2977.
2015
|
|
| 2015
|
A national study of outcomes among HIV-infected kidney transplant recipients.
Journal of the American Society of Nephrology.
26:2222-2229.
2015
|
|
| 2015
|
Center-Level Experience and Kidney Transplant Outcomes in HIV-Infected Recipients.
American Journal of Transplantation.
15:2096-2104.
2015
|
|
| 2015
|
The biomechanics of pedicle screw augmentation with cement
2015
|
|
| 2015
|
A Systematic Assessment of the Use of Platelet-Rich Plasma in Spinal Fusion.
Journal of bioengineering.
43:1057-1070.
2015
|
|
| 2015
|
The impact of proposed changes in liver allocation policy on cold ischemia times and organ transportation costs.
American Journal of Transplantation.
15:541-546.
2015
|
|
| 2015
|
Identification of strategies to facilitate organ donation among african americans using the nominal group technique.
Clinical Journal of the American Society of Nephrology.
10:286-293.
2015
|
|
| 2014
|
To whom goes the kidney?.
Liver Transplantation.
20:1017-1018.
2014
|
|
| 2014
|
The authors' reply.
Transplantation.
97.
2014
|
|
| 2014
|
Resource utilization associated with procurement of transplantable organs from donors that do not meet OPTN eligible death criteria.
Transplantation.
97:1043-1048.
2014
|
|
| 2014
|
Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients.
Transplantation.
97:446-450.
2014
|
|
| 2014
|
Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation.
Transplantation.
98:857-863.
2014
|
|
| 2014
|
Is there a role for detection of complement-binding antibodies in kidney transplantation?.
American Journal of Kidney Diseases.
63:558-560.
2014
|
|
| 2013
|
What liver transplant outcomes can be expected in the uninsured who become insured via the affordable care act?.
American Journal of Transplantation.
13:1533-1540.
2013
|
|
| 2012
|
Donor-derived organ transplant transmission of coccidioidomycosis.
Transplant Infectious Disease.
14:300-304.
2012
|
|
| 2012
|
Re: Desensitization in HLA-incompatible kidney recipients and survival.
Investigative urology.
187:1766-1767.
2012
|
|
| 2012
|
In vitro and ex vivo delivery of short hairpin RNAs for control of hepatitis C viral transcript expression.
JAMA Surgery.
147:384-387.
2012
|
|
| 2011
|
Late graft loss among pediatric recipients of DCD kidneys.
Clinical Journal of the American Society of Nephrology.
6:2705-2711.
2011
|
|
| 2011
|
Outcomes of renal transplants from centers for disease control and prevention high-risk donors with prospective recipient viral testing: A single-center experience.
JAMA Surgery.
146:1261-1266.
2011
|
|
| 2011
|
Desensitization in HLA-incompatible kidney recipients and survival.
New England Journal of Medicine.
365:318-326.
2011
|
|
| 2011
|
Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients..
Hepatic Medicine: Evidence and Research.
3:53-62.
2011
|
|
| 2010
|
Stem cell mobilization is life saving in an animal model of acute liver failure.
Annals of Surgery.
252:591-595.
2010
|
|
| 2010
|
Eculizumab, bortezomib and kidney paired donation facilitate transplantation of a highly sensitized patient without vascular access.
American Journal of Transplantation.
10:2154-2160.
2010
|
|
| 2010
|
Proinflammatory events and HLA antibodies..
American Journal of Transplantation.
10:956.
2010
|
|
| 2010
|
Renal transplantation in HIV-positive recipients.
Current Infectious Disease Reports.
12:71-75.
2010
|
|
| 2009
|
Impact of medicare coverage on disparities in access to simultaneous pancreas and kidney transplantation.
American Journal of Transplantation.
9:2785-2791.
2009
|
|
| 2009
|
Increased risk of graft loss from hepatic artery thrombosis after liver transplantation with older donors.
Liver Transplantation.
15:1688-1695.
2009
|
|
| 2009
|
Stem Cells and the Liver: Clinical Applications in Transplantation.
Advances in Surgery.
43:35-51.
2009
|
|
| 2009
|
Successful liver transplantation for Budd-Chiari syndrome in a patient with paroxysmal nocturnal hemoglobinuria treated with the anti-complement antibody eculizumab.
Liver Transplantation.
15:540-543.
2009
|
|
| 2009
|
Rapid accomodation of an a1 renal allograft after preconditioning for ABO-incompatible transplantation.
Contributions to Nephrology.
162:35-46.
2009
|
|
| 2009
|
Recruitment of host progenitor cells in rat liver transplants.
Hepatology.
49:587-597.
2009
|
|
| 2009
|
ABO incompatible renal transplantation: A paradigm ready for broad implementation.
Transplantation.
87:1246-1255.
2009
|
|
| 2009
|
ABO-incompatible deceased donor liver transplantation in the United States: A national registry analysis.
Liver Transplantation.
15:883-893.
2009
|
|
| 2009
|
C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts.
Journal of the American Society of Nephrology.
20:197-204.
2009
|
|
| 2009
|
Proinflammatory events are associated with significant increases in breadth and strength of HLA-specific antibody.
American Journal of Transplantation.
9:2136-2139.
2009
|
|
| 2009
|
Renal transplant in HIV-positive patients: Long-term outcomes and risk factors for graft loss.
JAMA Surgery.
144:83-86.
2009
|
|
| 2009
|
The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection.
American Journal of Transplantation.
9:231-235.
2009
|
|
| 2008
|
Prolonged waiting times for liver transplantation in obese patients.
Annals of Surgery.
248:863-870.
2008
|
|
| 2008
|
Donor ethnicity influences outcomes following deceased-donor kidney transplantation in black recipients.
Journal of the American Society of Nephrology.
19:2011-2019.
2008
|
|
| 2008
|
Generation of humanized animal livers using embryoid body-derived stem cell transplant.
Annals of Surgery.
248:487-491.
2008
|
|
| 2008
|
Can Machine Perfusion Decrease the Likelihood of Discard Among Biopsied Kidneys?.
Transplantation Proceedings.
40:1029-1031.
2008
|
|
| 2008
|
Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: Ineffective usage of renal allografts.
Transplantation.
85:935-942.
2008
|
|
| 2008
|
Effect modification in liver allografts with prolonged cold ischemic time.
American Journal of Transplantation.
8:658-666.
2008
|
|
| 2008
|
Obesity impacts access to kidney transplantation.
Journal of the American Society of Nephrology.
19:349-355.
2008
|
|
| 2007
|
ABO-incompatible transplantation: Less may be more.
Transplantation.
84.
2007
|
|
| 2007
|
Minimizing risk associated with elderly liver donors by matching to preferred recipients.
Hepatology.
46:1907-1918.
2007
|
|
| 2007
|
Twenty years of liver transplantation for Budd-Chiari syndrome: A national registry analysis.
Liver Transplantation.
13:1285-1294.
2007
|
|
| 2007
|
Desensitization protocols for crossing human leukocyte antigen and ABO incompatible barriers.
Current Opinion in Organ Transplantation.
12:371-378.
2007
|
|
| 2007
|
Outcomes of kidneys from donors after cardiac death: Implications for allocation and preservation.
American Journal of Transplantation.
7:1797-1807.
2007
|
|
| 2007
|
The utility of splenectomy as rescue treatment for severe acute antibody mediated rejection.
American Journal of Transplantation.
7:842-846.
2007
|
|
| 2007
|
Cold ischemia time and allograft outcomes in live donor renal transplantation: Is live donor organ transport feasible?.
American Journal of Transplantation.
7:99-107.
2007
|
|
| 2006
|
Factors affecting graft survival after liver transplantation from donation after cardiac death donors.
Transplantation.
82:1683-1688.
2006
|
|
| 2006
|
Biliary cystic disease.
Current Treatment Options in Gastroenterology.
9:107-112.
2006
|
|
| 2006
|
Rescue splenectomy for severe acute antibody-mediated rejection..
Clinical transplants.
518-520.
2006
|
|
| 2005
|
Inflammatory pseudotumor of the liver.
Journal of Hepato-Biliary-Pancreatic Sciences.
12:314-316.
2005
|
|
